Granahan Investment Management - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 208 filers reported holding NEKTAR THERAPEUTICS in Q3 2017. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2017$9,347,000
-19.5%
156,517
-67.6%
0.74%
-24.1%
Q3 2017$11,611,000
+29.3%
483,800
+5.4%
0.97%
+17.0%
Q2 2017$8,977,000
-32.0%
459,201
-18.4%
0.83%
-37.6%
Q1 2017$13,201,000
-40.8%
562,473
-69.0%
1.32%
+73.0%
Q4 2016$22,286,000
-34.9%
1,816,305
-8.9%
0.77%
-31.7%
Q3 2016$34,242,000
+21.5%
1,993,125
+0.6%
1.12%
+9.2%
Q2 2016$28,180,000
-0.1%
1,980,335
-3.5%
1.03%
+0.1%
Q1 2016$28,213,000
-19.6%
2,051,835
-1.5%
1.03%
-15.0%
Q4 2015$35,084,000
+38.0%
2,082,155
-10.2%
1.21%
+53.4%
Q3 2015$25,424,000
-8.2%
2,319,675
+4.8%
0.79%
+0.4%
Q2 2015$27,682,000
+13.5%
2,212,775
-0.2%
0.78%
+12.3%
Q1 2015$24,386,000
-55.2%
2,216,945
-36.8%
0.70%
-56.0%
Q4 2014$54,405,000
+30.9%
3,509,990
+1.9%
1.59%
+23.8%
Q3 2014$41,557,000
-11.8%
3,442,980
-6.3%
1.28%
-6.7%
Q2 2014$47,105,000
+5.2%
3,674,326
-0.5%
1.38%
+14.0%
Q1 2014$44,771,000
+22.2%
3,693,956
+14.4%
1.21%
+28.0%
Q4 2013$36,637,000
+29.2%
3,227,906
+18.9%
0.94%
+25.1%
Q3 2013$28,356,000
-14.9%
2,714,830
-5.9%
0.75%
-21.5%
Q2 2013$33,336,0002,886,2000.96%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2017
NameSharesValueWeighting ↓
Monaco Asset Management SAM 4,809,601$2,864,5980.85%
Lynx1 Capital Management LP 1,766,815$1,052,3150.70%
CM Management, LLC 800,000$476,4800.51%
Deep Track Capital, LP 18,400,000$10,959,0400.42%
TANG CAPITAL MANAGEMENT LLC 3,939,600$2,346,4260.33%
Acuitas Investments, LLC 721,460$429,7020.25%
RA Capital Management 18,700,000$11,137,7200.22%
GSA CAPITAL PARTNERS LLP 1,841,078$1,0970.09%
UBS OCONNOR LLC 1,376,249$820,2440.02%
Marquette Asset Management, LLC 148,378$88,3740.02%
View complete list of NEKTAR THERAPEUTICS shareholders